| Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma TF Cloughesy, AY Mochizuki, JR Orpilla, W Hugo, AH Lee, TB Davidson, ... Nature medicine 25 (3), 477-486, 2019 | 1092 | 2019 |
| Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ... Neuro-oncology 18 (9), 1199-1208, 2016 | 705 | 2016 |
| Immunotherapy response assessment in neuro-oncology: a report of the RANO working group H Okada, M Weller, R Huang, G Finocchiaro, MR Gilbert, W Wick, ... The Lancet Oncology 16 (15), e534-e542, 2015 | 678 | 2015 |
| Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ... Neuro-oncology 17 (9), 1188-1198, 2015 | 642 | 2015 |
| Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin A Lai, S Kharbanda, WB Pope, A Tran, OE Solis, F Peale, WF Forrest, ... Journal of clinical oncology 29 (34), 4482, 2011 | 524 | 2011 |
| Modified criteria for radiographic response assessment in glioblastoma clinical trials BM Ellingson, PY Wen, TF Cloughesy Neurotherapeutics 14 (2), 307-320, 2017 | 388 | 2017 |
| Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma JA Carrillo, A Lai, PL Nghiemphu, HJ Kim, HS Phillips, S Kharbanda, ... American Journal of Neuroradiology 33 (7), 1349-1355, 2012 | 308 | 2012 |
| Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity BM Ellingson, MG Malkin, SD Rand, JM Connelly, C Quinsey, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2010 | 308 | 2010 |
| Pseudoprogression, radionecrosis, inflammation or true tumor progression? Challenges associated with glioblastoma response assessment in an evolving therapeutic landscape BM Ellingson, C Chung, WB Pope, JL Boxerman, TJ Kaufmann Journal of neuro-oncology 134, 495-504, 2017 | 219 | 2017 |
| Probabilistic radiographic atlas of glioblastoma phenotypes BM Ellingson, A Lai, RJ Harris, JM Selfridge, WH Yong, K Das, WB Pope, ... American Journal of neuroradiology 34 (3), 533-540, 2013 | 211 | 2013 |
| Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma IK Mellinghoff, BM Ellingson, M Touat, E Maher, MI De La Fuente, ... Journal of clinical oncology 38 (29), 3398-3406, 2020 | 197 | 2020 |
| Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study WB Pope, XJ Qiao, HJ Kim, A Lai, P Nghiemphu, X Xue, BM Ellingson, ... Journal of neuro-oncology 108, 491-498, 2012 | 182 | 2012 |
| Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter … BM Ellingson, HJ Kim, DC Woodworth, WB Pope, JN Cloughesy, ... Radiology 271 (1), 200-210, 2014 | 180 | 2014 |
| Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome BM Ellingson, E Mayer, RJ Harris, C Ashe-McNally, BD Naliboff, JS Labus, ... PAIN® 154 (9), 1528-1541, 2013 | 171 | 2013 |
| Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases TJ Kaufmann, M Smits, J Boxerman, R Huang, DP Barboriak, M Weller, ... Neuro-oncology 22 (6), 757-772, 2020 | 160 | 2020 |
| 3′-deoxy-3′-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab J Schwarzenberg, J Czernin, TF Cloughesy, BM Ellingson, WB Pope, ... Journal of Nuclear Medicine 53 (1), 29-36, 2012 | 154 | 2012 |
| Diffusion tensor MR imaging in chronic spinal cord injury BM Ellingson, JL Ulmer, SN Kurpad, BD Schmit American journal of neuroradiology 29 (10), 1976-1982, 2008 | 153 | 2008 |
| Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas JL Boxerman, CC Quarles, LS Hu, BJ Erickson, ER Gerstner, M Smits, ... Neuro-oncology 22 (9), 1262-1275, 2020 | 144 | 2020 |
| Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics BM Ellingson Current neurology and neuroscience reports 15, 1-12, 2015 | 143 | 2015 |
| Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II–III diffuse gliomas K Leu, GA Ott, A Lai, PL Nghiemphu, WB Pope, WH Yong, LM Liau, ... Journal of neuro-oncology 134, 177-188, 2017 | 138 | 2017 |
Timothy CloughesyUCLAVerified email at mednet.ucla.edu
